Biotech · Private company

Coordination Pharmaceuticals, Inc.

Track this companyFree. Adds Coordination Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials72 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline7

RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck CancerPHASE2 · NOT_YET_RECRUITING · started Aug 1, 2026ClinicalTrials.gov NCT07732634 · fetched Nov 12, 2026
Phase I Study of RiMO-401 With Radiation in Advanced TumorsPHASE1 · TERMINATED · started Feb 22, 2024ClinicalTrials.gov NCT06182579 · fetched Nov 12, 2026
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck CancerPHASE1_PHASE2 · RECRUITING · started Apr 3, 2023ClinicalTrials.gov NCT05838729 · fetched Nov 12, 2026
Phase I Study of CPI-300 in Patients With Advanced TumorsPHASE1 · COMPLETED · started Jun 15, 2021ClinicalTrials.gov NCT04808453 · fetched Nov 12, 2026
Study of CPI-200 in Patients With Advanced TumorsPHASE1 · COMPLETED · started Jul 1, 2019ClinicalTrials.gov NCT03953742 · fetched Nov 12, 2026
Study of CPI-100 in Patients With Advanced TumorsPHASE1 · COMPLETED · started Dec 21, 2018ClinicalTrials.gov NCT03781362 · fetched Nov 12, 2026
Phase I Study of RiMO-301 With Radiation in Advanced TumorsPHASE1 · COMPLETED · started Apr 10, 2018ClinicalTrials.gov NCT03444714 · fetched Nov 12, 2026